GeneDx Holdings (WGS) Long-Term Investments (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Long-Term Investments of $442.8 million for Q2 2021, little changed sequentially from $442.8 million in Q1 2021.

GeneDx Holdings (WGS) Long-Term Investments (2020 - 2021) Analysis & Trends

GeneDx Holdings has disclosed Long-Term Investments across 2 years of filings, most recently posting $442.8 million for Q2 2021.

  • In Q2 2021, Long-Term Investments changed N/A year-over-year to $442.8 million; the TTM figure through Jun 2021 stood at $442.8 million (changed N/A YoY), while the FY2020 annual figure was $442.8 million, changed N/A from the prior year.
  • Long-Term Investments held at $442.8 million in Q2 2021, from $442.8 million in the prior quarter.
  • Over the last five years, Long-Term Investments for WGS reached as high as $442.8 million in Q2 2021 and fell as low as $442.8 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn -
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn -
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn 136.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 357.00 Mn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn -
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn -
10 GeneDx Holdings 2.10 Bn 1.93 Bn 68.21 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 442.79 Mn
Mar 31, 2021 442.77 Mn
Dec 31, 2020 442.76 Mn
Sep 30, 2020 442.75 Mn